Republic of Korea Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 70 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in This Report

3.1 Drug delivery devices

3.2 Inhalation Systems

3.2.1 Metered Dose Inhaler

3.2.2 Dry powder inhaler

3.3 Infusion Systems

3.3.1 Infusion pumps

3.3.2 Syringe pumps

3.3.3 Disposable Infusion sets

4 Healthcare Sector Review

4.1 Healthcare Expenditure

4.2 Healthcare Infrastructure

4.3 Healthcare Policy

5 Regulation System

5.1 Medical Equipment Approval Process

5.1.1 Classification

5.1.2 Premarket Notification for Class I Devices

5.1.3 Pre-market Approval for Class II, III and IV Devices

5.1.3.1 Technical Review:

5.1.3.2 Type Testing:

5.1.3.3 Applying for Product License:

5.1.3.4 KGMP Certification

5.1.4 License Fee

5.1.5 License Application Processing Duration

5.2 Post-market Surveillance

6 Pricing and Reimbursement

7 Distribution Structure

7.1 Distribution Structure

8 Drug Delivery Devices In Republic of Korea

8.1 Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015

8.2 Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2015

8.3 Drug Delivery Devices, Republic of Korea, Company Share (2007-2008)

9 Infusion Systems In Republic of Korea

9.1 Infusion Systems Overall Revenue (2000-2015)

9.2 Infusion Systems Overall Volume (2000-2015)

9.3 Infusion Systems Average Price (2000-2015)

9.4 Infusion Systems Distribution Share (2007-2008)

9.5 Infusion Systems, Republic of Korea, Company Share (2007-2008)

10 Inhalation Systems In Republic of Korea

10.1 Inhalation Systems Overall Revenue (2000-2015)

10.2 Inhalation Systems Overall Volume (2000-2015)

10.3 Inhalation Systems Average Price (2000-2015)

10.4 Inhalation Systems Distribution Share (2007-2008)

10.5 Inhalation Systems, Republic of Korea, Company Share (2007-2008)

11 Overview of Key Companies in Republic of Korea Drug Delivery Devices Market

11.1 AstraZeneca PLC

11.1.1 Company Overview

11.2 Boehringer Ingelheim GmbH

11.2.1 Company Overview

11.3 Baxter International Inc.

11.3.1 Company Overview

11.4 Novartis AG

11.4.1 Company Overview

11.5 Terumo Corporation

11.5.1 Company Overview

11.5.2 Terumo Corporation Pipeline Products

11.5.2.1 Terumo Corporation Pipeline Products By Equipment Type

11.5.2.2 Terumo Corporation Pipeline Products By Development Stage

11.5.2.3 Terumo Corporation Pipeline Products By Therapy Area

11.5.2.4 Terumo Corporation Pipeline Products By Clinical Trials

11.5.2.5 Terumo Corporation Pipeline Products By News Summary

11.6 Cardinal Health, Inc.

11.6.1 Company Overview

11.7 GlaxoSmithKline plc

11.7.1 Company Overview

11.8 B. Braun Melsungen AG

11.8.1 Company Overview

11.9 Smiths Medical

11.9.1 Company Overview

11.10 Fresenius Kabi AG

11.10.1 Company Overview

11.11 Consort Medical plc

11.11.1 Company Overview

11.11.2 Consort Medical plc Pipeline Products

11.11.2.1 Bespak plc Pipeline Products By Equipment Type

11.11.2.2 Bespak plc Pipeline Products By Development Stage

11.11.2.3 Bespak plc Pipeline Products By Therapy Area

11.12 Shin Chang Medical Co., Ltd.

11.12.1 Company Overview

11.13 Woo Young Medical Co., Ltd.

11.13.1 Company Overview

11.14 Hospira, Inc.

12 Financial Deals Landscape

12.1 Partnerships

12.1.1 BioChemics Signs an Agreement With Pacific Pharmaceutical

12.1.2 Novartis Terminates Its Licensing Agreement With NexMed

12.1.3 Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals

12.1.4 Teikoku Pharma Enters Into An Agreement With Eisai

13 Appendix

13.1 Global Markets Direct Research Methodology

13.2 Secondary Research

13.3 Primary Research

13.4 Models

13.5 Forecasts

13.6 Expert Panel Validation

13.7 Currency Conversion

13.8 Contact Us

13.9 Disclaimer

1.1 List of Tables

Table 1: Total Healthcare Expenditure, Republic of Korea, 2000 - 2007

Table 2: Hospital Wards by Specialty in Republic of Korea, 2003-2007

Table 3: Doctors by Specialty in Republic of Korea, 2003-2007

Table 4: Healthcare Institutions in Republic of Korea, 2001-2005

Table 5: Healthcare Personnel in Republic of Korea, 1975-2002

Table 6: Classification of Medical Equipment in Republic of Korea

Table 7: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015

Table 8: Drug Delivery Devices, Republic of Korea, Cross-Category Analysis, 2000-2015

Table 9: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Historic, 2000-2008

Table 10: Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Forecast, 2008-2015

Table 11: Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2015

Table 12: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2008

Table 13: Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2008-2015

Table 14: Drug Delivery Devices, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008

Table 15: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 16: Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 17: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008

Table 18: Infusion Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2008-2015

Table 19: Infusion Systems, Republic of Korea, Average Price ($), Historic, 2000-2008

Table 20: Infusion Systems, Republic of Korea, Average Price ($), Forecast, 2008-2015

Table 21: Infusion Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2007-2008

Table 22: Infusion Systems, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008

Table 23: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008

Table 24: Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015

Table 25: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008

Table 26: Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2008-2015

Table 27: Inhalation Systems, Republic of Korea, Average Price ($), Historic, 2000-2008

Table 28: Inhalation Systems, Republic of Korea, Average Price ($), Forecast, 2008-2015

Table 29: Inhalation Systems, Republic of Korea, Distribution Share by Revenue ($mn), 2007-2008

Table 30: Inhalation Systems, Republic of Korea, Company Share by Revenue ($ mn), 2007-2008

Table 31: Terumo Corporation Pipeline Products by Equipment Type

Table 32: Terumo Corporation Pipeline Products By Development Stage

Table 33: Terumo Corporation Pipeline Products By Therapy Area

Table 34: Terumo Corporation Pipeline Products By Clinical Trials

Table 35: Terumo Corporation Pipeline Products By News Summary

Table 36: Bespak plc Pipeline Products by Equipment Type

Table 37: Bespak plc Pipeline Products By Development Stage

Table 38: Bespak plc Pipeline Products By Therapy Area

Table 39: BioChemics Signs An Agreement With Pacific Pharmaceutical

Table 40: Novartis Terminates Its Licensing Agreement With NexMed

Table 41: Echo Therapeutics Enters Into Licensing Agreement With HANDOK Pharmaceuticals

Table 42: Teikoku Pharma Enters Into An Agreement With Eisai

Table 43: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1: Total Healthcare Expenditure, Republic of Korea, 2000 - 2007

Figure 2: Government and Private Healthcare Expenditure in Republic of Korea, 2007

Figure 3: Healthcare Financing in Republic of Korea, 2007

Figure 4: Evaluation (Value Appraisal) Criteria for Medical Device Reimbursement in Republic of Korea, 2007

Figure 5: Medical Device Pricing System in Republic of Korea, 2007

Figure 6 Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), 2000-2015

Figure 7 Drug Delivery Devices, Republic of Korea, Cross-Category Analysis, 2000-2015

Figure 8 Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Historic, 2000-2008

Figure 9 Drug Delivery Devices, Republic of Korea, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 10 Drug Delivery Devices, Republic of Korea, Category Volume (Units), 2000-2015

Figure 11 Drug Delivery Devices, Republic of Korea, Category Volume (Units), Historic, 2000-2008

Figure 12 Drug Delivery Devices, Republic of Korea, Category Volume (Units), Forecast, 2008-2015

Figure 13 Drug Delivery Devices, Republic of Korea, Company Share (%), 2008

Figure 14 Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 15 Infusion Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 16 Infusion Systems, Republic of Korea, Company Share (%), 2008

Figure 17 Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Historic, 2000-2008

Figure 18 Inhalation Systems, Republic of Korea, Revenue ($ mn) by Segment, Forecast, 2008-2015

Figure 19 Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Historic, 2000-2008

Figure 20 Inhalation Systems, Republic of Korea, Volume (Units) by Segment, Forecast, 2008-2015

Figure 21 Inhalation Systems, Republic of Korea, Company Share (%), 2008

Figure 22 Global Markets Direct Methodology

Abstract

• The report provides information on the drug delivery devices market in Republic of Korea.
• Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors such as AstraZeneca International plc, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Novartis AG, and Baxter International Inc.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in Republic of Korea.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.